YOLFTbeta
Alterity Therapeutics Ltd

Alterity Therapeutics Ltd

ATH · AU · Healthcare / Biotechnology

0.25AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.25
Open0.245
Day Range0.24 – 0.25
52-Week Range0.35 – 0.785
Volume62.65K
Market Cap83.03M
P/E (TTM)0.00
Forward P/E10.33
EPS-0.11
Dividend Yield0.00%
Beta-0.04
50-Day Avg0.4891
200-Day Avg0.4712

About

Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson's disease. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; and ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy, as well as bioMUSE, biomarkers of progression in multiple system atrophy. The company also operates drug discovery platform that generates patentable chemical compounds to treat the underlying pathology of neurological diseases. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is based in Melbourne, Australia.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. David A. Stamler M.D.
  • Employees11
  • Headquarters500 Collins Street, Melbourne, VIC, Australia, 3000, Australia
  • Websitehttps://alteritytherapeutics.com

Leadership

  • Dr. David A. Stamler M.D.CEO, MD & Director · b. 1961
  • Ms. Abby Macnish Niven B.Com., B.Sc., C.F.A.CFO & Company Secretary · b. 1982
  • Dr. Rudolph Emile Tanzi Ph.D.Chief Scientific Advisor and Member of Research & Development Advisory Board · b. 1959
  • Dr. Steven D. Targum M.D.Chief Medical Advisor
  • Dr. Robert ChernyHead of Research

Financials

Income Statement

Currency: AUD1998-06-301999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue--78.76K516.18K794.39K1.81M2.31M2.64M762.49K507.04K492.00K428.19K215.01K156.13K186.66K150.87K363.77K176.84K142.66K132.40K201.17K108.54K17.12K4.34M5.12M3.92M4.02M5.44M0
Growth (%)---+555.40%+53.90%+127.98%+27.39%+14.53%-71.14%-33.50%-2.97%-12.97%-49.79%-27.38%+19.55%-19.18%+141.12%-51.39%-19.33%-7.19%+51.95%-46.05%-84.23%+25248.13%+18.06%-23.56%+2.63%+35.32%-100.00%
Cost of Revenue-------------399.24K--4.34M-7.85M257.30K22.81K21.33K21.80K29.70K112.43K360.03K364.67K285.07K214.30K127.52K115.54K
Gross Profit--78.76K516.18K794.39K1.81M2.31M2.64M762.49K507.04K492.00K428.19K215.01K-243.10K186.66K4.49M8.21M-80.46K119.85K111.07K179.38K78.84K-112.43K3.98M4.76M3.63M3.80M5.31M-115.54K
Gross Margin--100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%-155.70%100.00%2975.15%2256.66%-45.50%84.01%83.89%89.16%72.64%-656.70%91.70%92.88%92.72%94.67%97.66%-
Operating Expense--421.93K3.52M5.79M5.60M11.20M14.45M12.18M11.50M13.23M8.72M5.12M6.03M5.51M12.29M20.76M10.36M8.71M6.99M7.95M12.79M10.30M19.16M20.26M18.27M23.41M19.89M28.30M
Operating Income-690-80.00K-343.18K-3.00M-5.00M-3.79M-8.89M-11.81M-11.41M-10.99M-12.73M-8.29M-4.90M-6.28M-5.32M-7.80M-12.55M-10.44M-8.59M-6.88M-7.77M-12.71M-10.41M-15.18M-15.50M-14.64M-19.60M-14.57M-28.42M
Operating Margin---435.73%-581.36%-628.85%-209.40%-385.32%-446.85%-1496.86%-2167.55%-2588.19%-1935.69%-2279.38%-4020.25%-2849.27%-5171.41%-3450.60%-5901.05%-6019.19%-5197.94%-3862.48%-11713.74%-60829.56%-349.77%-302.56%-373.72%-487.69%-267.96%-
EBITDA-690-80.00K-343.18K-1.86M-3.83M-2.61M-7.70M-15.95M-12.12M-10.93M-12.68M-7.49M-4.87M-6.40M-5.21M-7.76M-12.53M-10.57M-8.56M-6.86M-11.37M-12.77M-13.34M-19.36M-17.39M-17.51M-19.46M-14.63M-28.30M
EBITDA Margin---435.73%-360.38%-482.67%-144.11%-333.83%-603.48%-1589.56%-2156.00%-2577.46%-1748.88%-2265.79%-4096.36%-2790.20%-5144.36%-3444.51%-5979.88%-6003.20%-5181.83%-5651.68%-11761.54%-77946.09%-446.13%-339.46%-447.20%-484.15%-269.05%-
Net Income-690-80.00K-1.33M-4.14M-5.45M-4.57M-9.83M-24.91M-11.73M-11.14M-13.59M-7.52M-4.91M-6.43M-5.24M-7.79M-13.33M-5.89M-7.73M-7.54M-8.27M-11.96M-10.06M-15.31M-12.85M-13.81M-19.12M-12.15M-23.40M
Net Income Margin---1684.00%-801.84%-686.23%-252.40%-425.88%-942.61%-1537.92%-2197.05%-2762.17%-1756.87%-2282.20%-4118.99%-2806.90%-5161.66%-3664.14%-3327.87%-5418.28%-5696.60%-4108.75%-11020.84%-58759.84%-352.78%-250.75%-352.54%-475.79%-223.35%-
R&D--421.93K2.38M2.48M1.86M5.20M7.66M7.62M4.49M5.77M2.22M87.99K2.33M4.23M7.95M14.91M12.30M9.59M5.70M6.70M12.98M10.10M12.28M14.75M13.20M18.64M14.40M17.63M
R&D as % of Total Revenue--535.73%460.38%312.35%102.47%225.42%289.76%999.06%885.77%1172.68%517.37%40.92%1491.97%2265.42%5266.89%4098.16%6954.32%6719.17%4305.52%3329.46%11961.88%58983.93%283.06%287.81%337.01%463.86%264.84%-
Interest Expense00000000000003.76K11.54K17.68K29.98K00000002.50K----
Interest Expense % of Total Revenue--0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%2.41%6.18%11.72%8.24%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.05%----

Balance Sheet

Currency: AUD1998-06-301999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets199.28K1.84M20.88M22.29M17.59M16.34M41.16M22.20M10.43M7.72M11.72M4.60M6.80M9.01M7.34M17.07M41.64M41.83M33.73M25.28M18.73M19.91M13.30M33.59M41.36M27.32M19.22M46.03M46.02M
Total Liabilities199.96K1.92M147.14K894.58K912.82K564.54K2.70M2.68M1.69M2.11M1.84M847.43K1.57M2.08M1.72M3.10M3.95M2.72M2.36M1.59M2.64M3.36M2.76M3.12M5.89M4.50M5.43M3.62M3.29M
Total Equity-670-80.67K20.73M21.39M16.68M15.78M38.47M19.51M8.73M5.61M9.89M3.75M5.23M6.93M5.62M13.97M37.69M39.11M31.37M23.69M16.08M16.55M10.55M30.47M35.47M22.81M13.80M42.40M42.72M
Cash20204.47M6.85M3.59M3.45M29.40M21.37M10.02M7.41M11.24M4.30M5.23M8.84M5.64M13.35M34.17M34.91M28.59M21.88M15.24M14.40M9.20M28.12M34.81M15.77M12.64M33.16M37.32M
Total Debt-------------285.79K299.01K802.64K-----33.75K33.75K65.65K117.49K210.38K159.04K155.46K193.47K
Net Debt-20-20-4.47M-6.85M-3.59M-3.45M-29.40M-21.37M-10.02M-7.41M-11.24M-4.30M-5.23M-8.55M-5.34M-12.54M-34.17M-34.91M-28.59M-21.88M-15.24M-14.40M-9.16M-28.05M-34.69M-15.56M-12.48M-33.00M-37.12M

Cash Flow

Currency: AUD2002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow-3.77M-3.58M-5.31M-11.37M-11.66M-9.20M-9.41M-6.99M-4.71M-4.56M-6.85M-7.95M-13.79M-10.87M-7.42M-5.87M-6.25M-13.95M-9.43M-17.33M-12.34M-20.04M-12.61M-11.45M-22.52M
Investing Cash Flow-84.28K-87.67K-133.55K-50.26K-55.28K-4.26K-81.95K-36.19K-22.67K-16.36K-26.76K-28.15K-23.05K-182.83K-833-27.92K-18.42K-7.02K-16.74K-10.47K-89.15K-36.46K-5.72K-7.50M7.50M
Financing Cash Flow580.65K3.56M31.59M4.69M-2.02K7.37M13.75M100.81K5.66M8.34M3.62M15.58M35.21M6.84M152.60K-159.56K-107.68K12.72M3.98M36.69M16.30M124.34K9.22M39.67M19.13M
Capital Expenditure84.28K87.67K133.55K50.26K55.66K4.56K46.71K36.19K22.67K13.69K26.76K22.00K23.05K28.76K2.31K27.92K62.41K7.02K16.74K10.47K89.15K7.31K5.72K222.52M
Free Cash Flow-3.85M-3.67M-5.45M-11.42M-11.71M-9.20M-9.46M-7.03M-4.73M-4.57M-6.87M-7.97M-13.81M-10.90M-7.42M-5.89M-6.31M-13.96M-9.45M-17.34M-12.43M-20.04M-12.61M-11.45M-22.52M
Dividends Paid------------------0000---
FCF to OCF102.24%102.45%102.51%100.44%100.48%100.05%100.50%100.52%100.48%100.30%100.39%100.28%100.17%100.26%100.03%100.48%101.00%100.05%100.18%100.06%100.72%100.04%100.05%100.00%100.00%
Dividend Paid to FCF------------------0.00%0.00%0.00%0.00%---

Earnings

Report DateFeb 25, 2016Sep 30, 2016Oct 1, 2016Feb 24, 2017Aug 31, 2017Feb 28, 2018May 30, 2018Aug 31, 2018Nov 28, 2018Feb 28, 2019May 29, 2019Aug 30, 2019Nov 27, 2019Feb 27, 2020Jun 3, 2020Aug 31, 2020Dec 2, 2020Feb 25, 2021Apr 29, 2021Sep 2, 2021Dec 1, 2021Feb 28, 2022Jun 1, 2022Jul 22, 2022Dec 26, 2022Feb 28, 2023May 31, 2023Aug 31, 2023Dec 29, 2023Feb 28, 2024May 29, 2024Aug 29, 2024Nov 27, 2024Feb 28, 2025May 28, 2025Aug 28, 2025Dec 3, 2025Feb 26, 2026
EPS Estimate0.000.000.000.000.000.000.00-0.000.000.000.000.000.000.000.000.000.000.000.00-0.000.000.00-0.000.00-0.000.000.000.000.000.000.000.000.000.000.000.000.00
EPS Actual-0.01-0.01-0.01-0.01-0.01-0.010.00-0.010.00-0.010.00-0.010.00-0.010.000.000.00-0.010.00-0.000.000.000.00-0.010.00-0.010.00-0.000.00-0.00-0.000.000.00-0.000.000.000.000.00
Surprise--------9900.00%----------------5600.00%--5400.00%------------
Timing-----------After-hours-After-hours-After-hours-After-hoursAfter-hoursPre-market-After-hours-Pre-marketPre-marketPre-market-After-hoursPre-market---------

Key Statistics & Ratios

Market Cap83.03M
Enterprise Value55.74M
Trailing P/E0.00
Forward P/E10.33
PEG Ratio1.29
Price / Sales23.00
Price / Book2.17
EPS-0.11
Book Value0.196
Revenue (TTM)3.61M
Gross Profit (TTM)3.35M
EBITDA-25.09M
Profit Margin0.00%
Operating Margin-1816.16%
Return on Equity-54.98%
Return on Assets-34.08%
Shares Outstanding218.50M
Shares Float171.39M
Beta-0.04
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jun 3, 20261:50